The B-AR project is based on a retrospective analysis of amyloidosis typing and the identification of their amylogenic protein.This work should be able to unite many clinicians, including pulmonologists and pathologists around a rare disease that still suffers from insufficient data.
The B-AR study will highlight the interest of proteomic analysis of amyloidosis compared to their identification by immunostaining. The objective is to reduce diagnostic wandering and to improve patient management. The typing of respiratory amyloidosis will allow a better characterization of the disease and thus, to propose a dedicated therapeutic management.
Study Type
OBSERVATIONAL
Enrollment
70
Number of cases with identification of the amylogenic protein in respiratory amyloidosis.
Identification of amylogenic protein by Proteomic Analysis Based on Tandem Mass Spectrometry on histological sample of the tracheobronchial or pulmonary tree.
Time frame: 1 day (at inclusion)
Distribution and severity of amyloidosis
association between typing and respiratory involvement
Time frame: 1 day (at inclusion)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.